Stock Research: Equasens

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Equasens

ENXTPA:PHA FR0012882389
68
  • Value
    80
  • Growth
    19
  • Safety
    Safety
    44
  • Combined
    42
  • Sentiment
    70
  • 360° View
    360° View
    68
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Equasens SA, formerly Pharmagest Interactive SA, is a France-based company specializing in software solutions for healthcare. It operates in the healthcare IT sector, providing software for pharmacies, hospitals, and other health establishments. Its main region of operation is France. In the last fiscal year, the company had a market cap of $887 million, profits of $154 million, and revenue of $224 million.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 68 (better than 68% compared with alternatives), overall professional sentiment and financial characteristics for the stock Equasens are above average. The 360° View is based on consolidating four consolidated indicators, with half below and half above average for Equasens. The consolidated Sentiment Rank has a good rank of 70, which means that professional investors are more optimistic about the stock than for 70% of alternative investment opportunities. It also rates well regarding its financing structure, with the consolidated Safety Rank at 80 or better than 80% of its peers when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the stock is expensive and expects low growth. The consolidated Value Rank is only 44, meaning that the share price of Equasens is on the high side, compared with indicators such as revenues, profits, and invested capital. The company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, invested capital growth,and stock returns, with its Growth Rank at 19. ...read more

more
Index
CAC All
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Nov-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
44 65 61 50
Growth
19 31 31 19
Safety
Safety
80 70 67 53
Sentiment
70 98 92 34
360° View
360° View
68 87 79 23
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
84 95 82 100
Opinions Change
13 50 50 50
Pro Holdings
n/a 77 80 1
Market Pulse
75 83 77 20
Sentiment
70 98 92 34
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
44 65 61 50
Growth
19 31 31 19
Safety Safety
80 70 67 53
Combined
42 65 51 25
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
61 67 56 56
Price vs. Earnings (P/E)
29 34 38 38
Price vs. Book (P/B)
50 50 46 38
Dividend Yield
75 84 86 68
Value
44 65 61 50
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
34 72 49 42
Profit Growth
29 8 46 53
Capital Growth
49 82 35 38
Stock Returns
47 31 17 15
Growth
19 31 31 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
64 57 51 41
Refinancing
47 31 37 33
Liquidity
88 88 92 79
Safety Safety
80 70 67 53

Similar Stocks

Discover high‑ranked alternatives to Equasens and broaden your portfolio horizons.

Ipsen

ENXTPA:IPN
Country: France
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Rubis

ENXTPA:RUI
Country: France
Industry: Gas Utilities
Size: Medium
Full Stock Analysis

Drägerwerk

XTRA:DRW3
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

Synergie

ENXTPA:SDG
Country: France
Industry: HR- & Employment Services
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.